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Endophthalmitis is potentially the most devastating complication of cataract surgery. For the purpose of this perspective it will be defined as intraocular infection attributed to elective cataract extraction with or without intraocular lens implantation. Ideally, all cases of endophthalmitis would be culture proved but culture negative cases that respond to antibiotic therapy are presumed to be infectious in origin despite lack of definitive proof. To this end, truly sterile postoperative inflammation resulting from phacoanaphylaxis is excluded. However, in phacoanaphylaxis it has been postulated that bacteria act as an adjuvant in stimulating a response to lens protein.' Additionally, the. exaggerated uveitic response resulting from excessive manipulation or the introduction of foreign material will also be excluded.
There are many controversies and ambiguities in the area of postoperative endophthalmitis, particularly in relation to prevention and management. These usually reflect the large numbers required to make meaningful statements or the assumptions made in extrapolating from animal models to the infected pseudophakic eye. Within the constraints of this article six questions will be asked:
What is the incidence? What are the causes? How does it present? How can it be managed? What is the outcome? How can it be prevented?
What is the incidence?
Most authors are agreed that the incidence of endophthalmitis following cataract surgery is declining. Good historical perspectives are provided by Forster,2 Kattan et al,3 and Fahmy.4 It would appear that during this century the incidence has fallen from 1-5% to the region of 0-1%. This improvement has been attributed to better instrumentation allowing more precise surgery, improved operating theatre technique and the use of prophylactic antibiotics. 25 The incidence derived from classic studies6 may not relate to modern surgical practice. It is important to know the incidence in relation to current techniques of extracapsular extraction or phacoemulsification with or without lens implantation. The effect of any modification or new procedure has to be related to this figure. Additionally, the rate following secondary lens implantation seems to be higher (0 3%).3 In any study it is difficult to control for all the possible variables -for instance, the type of conjunctival flap,7 the use and choice of prophylactic antibiotics, and the composition of the implant.8 However, no matter how good the technique endophthalmitis will inevitably appear. It is possible that the true incidence is higher than suspected from studies because of underreporting.2 This could be particularly true of chronic infection which may be treated as persistent uveitis.' While phacoanaphylaxis may cause chronic inflammation, in the first instance endophthalmitis should be suspected.
In order to get the best modem estimate, an average has been calculated from recent published series. Unfortunately there are no modem series relating to practice in the British Isles and American studies form the basis of the estimate. This is unsatisfactory as there are likely to be differences in the population and practice that could affect the incidence. Risk factors should be assessed independently. Complicated cases are at higher risk and their exclusion will give a baseline on which to work. 9 Two recent studies are summarised in 7 Fungal isolates frequently come from one of the families listed in Table 3 .
How does it present? The endophthalmitis following cataract surgery falls into three groups; acute, delayed acute, and chronic. Delayed acute has features similar to acute onset but is usually associated with some complication -for instance, a broken suture'8 or suture removal," an inadvertent filtering bleb," wound dehiscence," or a vitreous wick.2" Some authors identify the 30th postoperative day as the division between 'early' and 'delayed onset'.'8 While chronic endophthalmitis can present early it is differentiated by its more indolent course.
The development of infection is dependent on the relative virulence of the organism, the size of the inoculum, and the patient's resistance to infection.2' Additionally, the clinical picture on presentation is related to the delay before treatment is sought. The disease process may have been modified by the use of antibiotics or steroids. Acute endophthalmitis typically presents [2] [3] [4] Table 4 .
How is it managed? Two main issues have to be addressed -namely, how to identify the infecting organism and how to deliver sufficiently high antibiotic concentrations within the eye. A subsidiary is whether removing infected contents -for instance, aspirating a hypopyon, removing the implant and capsule, or performing a vitrectomy, is valuable as a form of 'incision and drainage' . 25 Apart from the delayed acute form it can be assumed that the infecting organism gained access at the time of surgery. When intraocular infection is suspected cultures should be taken at the earliest opportunity; however, there is some debate as to the best source of material. There is little to be gained from conjunctival swabs. Initially, provided there is no vitreous communication, the posterior capsule will act as a barrier and infection is probably located within the anterior chamber. Unfortunately, this is not the case for long and in acute endophthalmitis infection rapidly spreads to the vitreous cavity. A number of studies have shown the advantages ofvitreous biopsy'5 26 and as it is inappropriate to wait for the result ofan anterior chamber tap, both are recommended.
However, Driebe et al'5 did have two cases with positive anterior chamber taps and negative vitreous cultures. These cases had intact posterior capsules with posterior chamber lenses. They postulate that under these conditions infection may be limited to the anterior chamber and this seems to be supported by Heaven et with ceftazidime showing promise as an intravitreal agent.' Furthermore, probenecid slows the removal of antibiotics that are actively transported from the eye -for example, the cephalosporins, and may be of some benefit.35 In acute endophthalmitis the use of two agents is recommended to provide the widest possible cover, while vancomycin can be used alone in chronic endophthalmitis.'9 Intraocular injections must be given slowly and into midcavity to avoid retinal damage. They are not an alternative to other treatments but should be given in conjunction with both subconjunctival and topical antibiotics. Subconjunctival vancomycin (25 mg) and ceftazidime (100 mg) together with topical vancomycin and amikacin form part of the regimen adopted by the Endophthalmitis Vitrectomy Study Group.5 Care has to be taken when interpreting data on the half life of antibiotics in the vitreous. A variety of factors affect the persistence of antibiotics in the eye -for example, whether the drug is actively secreted as in the case of the cephalosporins or passively lost from the eye as occurs with gentamicin, the presence of the lens or posterior capsule, infection, and whether or not a vitrectomy has been performed. It may not be feasible to extrapolate from animal studies on the half life of antibiotics. Bearing this in mind it is probably safe to repeat intravitreal antibiotics after 48 hours, if no improvement is evident.2 However, Mandell et al32 have recently demonstrated that the concentration of amikacin is likely to be below therapeutic levels within 24 hours. 32 The choice agent for subsequent injection should be altered in the light of culture results but it is reasonable to repeat with the same agents if these are not available.
The role of vitrectomy in endophthalmitis is controversial and it is hoped that the current multicentre study being conducted in the United States will answer important questions.5 The dilemma for the clinician is that while animal studies have shown the benefit of vitrectomy and intravitreal injection over injection alone in sterilising the eye36 the procedure is not a simple one or risk free. Stern et al 18 suggest a simple protocol which can be used pending definitive results. Endophthalmitis is categorised into mild to moderate (<15% hypopyon) and severe (>15% hypopyon, no red reflex). The suggested protocol is outlined in Figure 1 . Ultrasound scanning has been advocated as a method of assessing vitreous activity and grading severity. 37 Peyman has advocated the use of antibiotics in the infusion fluids during vitrectomy to avoid the need for bolus injection and theoretically reducing the risk of toxicity.38 In general, the posterior capsule and intraocular lens can be preserved. However, in chronic endophthalmitis associated with Propionibacterium acnes if partial capsulectomy removing the plaque proves unsuccessful, a total capsulectomy and lens removal are warranted. ' In the rare case of a fungal infection intravitreal amphotericin B (0 005-0-O1 mg in 01 ml) has been recommended.219 This may be combined with intravitreal miconazole (0-025 mg in 0 1 ml.2 A sub-Tenon injection of miconazole or amphotericin B is administered together with topical antifungal preparations. To avoid toxicity systemic treatment is avoided but the situation needs to be kept under review and the use of oral imidazoles should be considered. 18 The last issue that must be dealt with is the use of corticosteroids in combating the destructive effects of the inflammatory reaction on the eye. Steroids have been advocated by all routes (topical, subconjunctival, intravitreal, and systemic) but should be avoided if fungal endophthalmitis is suspected.2 While Forster2 recommends subconjunctival triamcinolone 40 mg or dexamethasone 4 0 mg, Diamond37 suggests dexamethasone 0 4 mg given intravitreally. However, Baum39 in a comment on the work of Maxwell et al ' notes that there is no evidence regarding the best method of delivering corticosteroids to the eye. 19 23 Success could be measured by comparing visual results with preinfection vision rather than vision on presentation. Visual rehabilitation after cataract surgery is now so rapid that best postoperative vision should be used as the bench mark. While visual outcome relates to the severity of infection, it is well known that culture negative endophthalmitis has a relatively good prognosis, but endophthalmitis due to Staphylococcus aureus, Streptococcus pneumoniae, or Gram negative organisms is poor.2 Often vitrectomy is reserved for the most serious disease and this may be the reason why presumed benefits of vitrectomy have not been substantiated.5 Any comparison between therapeutic regimens must include an assessment of severity and a grading system is needed.
The visual outcomes of the series of acute pseudophakic endophthalmitis published by Driebe et al'" and Heaven et al"2 are outlined in Tables 5 and 6 . In both series Staphylococcus epidermidis comprises the most common organism isolated and there is agreement that visual results are second only to the culture negative group. Heaven et al document the range of complications from evisceration through presumed antibiotic toxicity to retinal detachment, macular pucker, and oedema. Chronic endophthalmitis has a relatively good prognosis as outlined in Table 7 , although relapses may occur. '8 How can it be prevented? Despite improvements in treatment, visual outcome after endophthalmitis is often poor and prevention is of utmost Recently, interest has been growing regarding the use of antibiotics in the irrigating solutions. To our knowledge no formal clinical trials have been published in relation to cataract surgery although a reduced infection rate has been claimed in correspondence. 7 This technique has been advocated for routine vitreoretinal surgery. Maxwell and Diamond" describe a series of6000 elective procedures using 2 mg gentamicin per 500 ml of balanced salt solution without a single case of infection.
Povidone iodine solution (5%) has been shown to significantly reduce conjunctival and perilimbal flora.45 [56] [57] [58] The solution has not only broad antibacterial activity but is also effective against fungi and several viruses. Positive culture rates from the conjunctiva of normal eyes have been reduced from 60% or more to 9.6%56 and 17%4"5 using a combined regimen of topical antibiotics and irrigation with povidone iodine solution. The use of povidone iodine has been shown to reduce the endophthalmitis rate,8 but it should be stressed that the solution must remain in contact with the eye for several minutes. The ocular surface should be irrigated with saline before surgery as it has been suggested that endothelial toxicity may occur if significant amounts enter the eye.
The importance of a 'no touch' technique during surgery with the minimum amount of surgical manipulation and instrumentation are logical steps in the prevention of infection. Adhesive drapes which exclude the lashes and lid margins should be used but there is no evidence supporting the cutting of lashes and in any case potential pathogens reside on the lid surface and in lash roots. Irrigating solutions should not be allowed to pool in the conjunctival fornix as reflux may carry bacteria into the eye.'2 Accurate wound closure is considered to be of great importance. Driebe et al 5 in their retrospective analysis of 83 cases of pseudophakic endophthalmitis noted wound abnormalities in 22% at the time of diagnosis. These included vitreous wicks, visible wound leaks, wound ruptures or dehiscence, and inadvertent filtering blebs. They considered this a highly significant finding and felt that these defects contributed to the onset of infection. Speculation has arisen regarding sutureless surgery and endophthalmitis; however, in the absence of controlled studies the risk remains unproved.59 Certainly suture removal is implicated and every attempt should be made to avoid puffing the exposed end of a broken suture through the cornea. The anterior chamber seems to have a greater ability to resist infection than the vitreous and an intact posterior capsule is thought to be a protective barrier which hinders spread of infection from the anterior chamber. 
Conclusion
For most ophthalmologists cataract surgery forms the bulk of the surgical workload and endophthalmitis is an ever present risk. However, the incidence is so low that no individual will be able to prove independently the effectiveness or otherwise of a particular preventive measure or treatment regimen. Clinical trials will require the cooperation ofmultiple centres to achieve suitable numbers, but it is doubtful if all the possible variables could be accounted for. It With the current emphasis on audit there should be a method of reporting serious infection. As numbers are small it would probably be best to do this on a national basis.
Surgeons often feel responsible and may fear litigation, so care must be taken to ensure anonymity if underreporting is to be avoided. Such a reporting system would serve as the first step in identifying factors for further prospective studies.
